Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 3
2011 2
2015 6
2016 6
2017 5
2018 1
2019 4
2020 8
2021 5
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection.
Krähling V, Erbar S, Kupke A, Nogueira SS, Walzer KC, Berger H, Dietzel E, Halwe S, Rohde C, Sauerhering L, Aragão-Santiago L, Moreno Herrero J, Witzel S, Haas H, Becker S, Sahin U. Krähling V, et al. Mol Ther. 2023 Feb 1;31(2):374-386. doi: 10.1016/j.ymthe.2022.10.011. Epub 2022 Oct 27. Mol Ther. 2023. PMID: 36303436 Free PMC article.
Ebola Virus Activates IRE1α-Dependent XBP1u Splicing.
Rohde C, Pfeiffer S, Baumgart S, Becker S, Krähling V. Rohde C, et al. Among authors: krahling v. Viruses. 2022 Dec 30;15(1):122. doi: 10.3390/v15010122. Viruses. 2022. PMID: 36680162 Free PMC article.
Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.
Takamatsu Y, Krähling V, Kolesnikova L, Halwe S, Lier C, Baumeister S, Noda T, Biedenkopf N, Becker S. Takamatsu Y, et al. Among authors: krahling v. mBio. 2020 Feb 25;11(1):e02565-19. doi: 10.1128/mBio.02565-19. mBio. 2020. PMID: 32098814 Free PMC article.
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.
Behrens GMN, Barros-Martins J, Cossmann A, Ramos GM, Stankov MV, Odak I, Dopfer-Jablonka A, Hetzel L, Köhler M, Patzer G, Binz C, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Krähling V, Bernhardt G, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Hammerschmidt SI, Förster R. Behrens GMN, et al. Among authors: krahling v. Nat Commun. 2022 Aug 18;13(1):4872. doi: 10.1038/s41467-022-32527-2. Nat Commun. 2022. PMID: 35982040 Free PMC article.
Generation of therapeutic antisera for emerging viral infections.
Schmidt R, Beltzig LC, Sawatsky B, Dolnik O, Dietzel E, Krähling V, Volz A, Sutter G, Becker S, von Messling V. Schmidt R, et al. Among authors: krahling v. NPJ Vaccines. 2018 Oct 5;3:42. doi: 10.1038/s41541-018-0082-4. eCollection 2018. NPJ Vaccines. 2018. PMID: 30323953 Free PMC article.
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test.
Roessler J, Pich D, Albanese M, Wratil PR, Krähling V, Hellmuth JC, Scherer C, von Bergwelt-Baildon M, Becker S, Keppler OT, Brisson A, Zeidler R, Hammerschmidt W. Roessler J, et al. Among authors: krahling v. PNAS Nexus. 2022 May;1(2):pgac045. doi: 10.1093/pnasnexus/pgac045. Epub 2022 Apr 14. PNAS Nexus. 2022. PMID: 36382127 Free PMC article.
Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years.
Romero-Olmedo AJ, Schulz AR, Hochstätter S, Gupta DD, Hirseland H, Staudenraus D, Camara B, Volland K, Hefter V, Sapre S, Krähling V, Müller-Kräuter H, Chung HR, Mei HE, Keller C, Lohoff M. Romero-Olmedo AJ, et al. Among authors: krahling v. Lancet Infect Dis. 2022 May;22(5):588-589. doi: 10.1016/S1473-3099(22)00219-5. Epub 2022 Apr 6. Lancet Infect Dis. 2022. PMID: 35397209 Free PMC article. No abstract available.
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection.
Imre G, Krähling V, Eichler M, Trautmann S, Ferreirós N, Aman MJ, Kashanchi F, Rajalingam K, Pöhlmann S, Becker S, Meyer Zu Heringdorf D, Pfeilschifter J. Imre G, et al. Among authors: krahling v. iScience. 2021 Mar 5;24(4):102266. doi: 10.1016/j.isci.2021.102266. eCollection 2021 Apr 23. iScience. 2021. PMID: 33817572 Free PMC article.
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Fathi A, Dahlke C, Krähling V, Kupke A, Okba NMA, Raadsen MP, Heidepriem J, Müller MA, Paris G, Lassen S, Klüver M, Volz A, Koch T, Ly ML, Friedrich M, Fux R, Tscherne A, Kalodimou G, Schmiedel S, Corman VM, Hesterkamp T, Drosten C, Loeffler FF, Haagmans BL, Sutter G, Becker S, Addo MM. Fathi A, et al. Among authors: krahling v. Nat Commun. 2022 Jul 19;13(1):4182. doi: 10.1038/s41467-022-31557-0. Nat Commun. 2022. PMID: 35853863 Free PMC article.
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV.
Ehrhardt SA, Zehner M, Krähling V, Cohen-Dvashi H, Kreer C, Elad N, Gruell H, Ercanoglu MS, Schommers P, Gieselmann L, Eggeling R, Dahlke C, Wolf T, Pfeifer N, Addo MM, Diskin R, Becker S, Klein F. Ehrhardt SA, et al. Among authors: krahling v. Nat Med. 2019 Oct;25(10):1589-1600. doi: 10.1038/s41591-019-0602-4. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591605 Clinical Trial.
48 results